Mapping the progress of alzheimer's and parkinson's disease
Author(s)
Bibliographic Information
Mapping the progress of alzheimer's and parkinson's disease
（Advances in behavioral biology, Vol. 51）
Kluwer Academic / Plenum Publishers, c2002
Available at / 5 libraries
-
No Libraries matched.
- Remove all filters.
Note
"Proceedings of the 5th International Conference on the Progress in Alzheimer's and Parkinson's Disease, held from March 31st to April 5th, 2001, in Kyoto, Japan"--T.p. verso
Proceedings of a joint conference
Includes bibliographical references and index
Description and Table of Contents
Description
1h The 5 International Conference on the Progress in Alzheimer's Disease and Parkinson's 51 1 Disease took place from March 31 to April 5 \ 2001 in Kroto, Japan. This international 1 conference was organized as a joint Congress with the 9 International Catecholamine Symposium. A total of 1258 clinicians and researchers participated in this joint congress 1h from 38 countries in the world. This book represents the proceedings of the 5 Conference on Alzheimer's and Parkinson's disease. The International Conference on the Progress in Alzheimer's and Parkinson's disease was first launched by Professor Abraham Fisher of Israel and Professor Israel Hanin of USA. The first conference was held in Eilat, Israel in 1985. The second conference was organized in Kyoto, Japan in 1989; the third one in Chicago, USA, in 1993, and the fourth one in Eilat, Israel in 1997. The International Catecholamine Symposium (ICS) is an international meeting devoted to the development of basic as well as clinical research on catecholamines. The first Catecholamine Symposium was held in Bethesda, USA in 1958. Since then this symposium has occurred every 5 years. Professor Toshiharu Nagatsu was appointed as 1h the president of the 9 International Catecholamine Symposium, which was to be held in 200 I also in Japan. Therefore, we decided to organize a joint congress of the two meetings, because there is much overlap in research between Alzheimer's disease, Parkinson's disease, and catecholamines. We thank Professor Nagatsu very much for agreeing to organizing this joint congress.
Table of Contents
Progress in Alzheimer's Disease. Etiology and Pathogenesis of Alzheimer's Disease. Familial Alzheimer's Disease and Biology of Presenilins. Animal Models of Alzheimer's Disease. Glycosaminoglycans (GAGs) in Alzheimer's Disease. Clinical Evaluation of Alzheimer's Disease. Progress in the Treatment of Alzheimer's Disease. Novel Drug Treatment of Alzheimer's Disease: Beyond Cholinesterase Inhibitors. New Treatment on the Horizon in Alzheimer's Disease.
Progress in Parkinson's Disease. Etiology and Pathogenesis. Familial Parkinson's Disease. Clinical Topics in Parkinson's Disease. Progress in the Treatment of Parkinson's Disease. Dopamine Agonists. Mechanism and Treatment of Motor Complications. Treatment of Depression and Cognitive Dysfunction in Parkinson's Disease. Surgical Treatment of Parkinson's Disease. New Treatment on the Horizon in Parkinson's Disease. Dementia With Lewy Bodies. Familial Frontotemporal Dementia and Related Disorders.
by "Nielsen BookData"